Skip to content

Medical-device intelligence

Idev Technologies, Inc.: FDA clearances and recalls

Research Idev Technologies, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

11 clearance records and 2 recall records in the covered releases, across 1 source company names and 4 product codes. Dated history runs from Sep 16, 2003 to May 2, 2013.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
IDEV Technologies SUPERA VERITAS Interwoven Self-Expanding Nitinol Stent Transhepatic Biliary System. Indicated for palliative treatment of bilia…Z-1550-2013 · FGEIDEV Technologies, Inc.RecallJun 18, 2013FDA classification date
SUPERA VERITASK130591 · FGEIdev Technologies, Inc.510(k)May 2, 2013FDA decision date
SUPERA VERITAS INTERWOVEN SELF-EXPANDING NITINOL STENT TRANSHEPATIC BILIARY SYSTEMK122546 · FGEIdev Technologies, Inc.510(k)Dec 7, 2012FDA decision date
SUPERA VERITAS(R) INTERWOVEN SELF-EXPANDING NITINOL STENT TRANSHEPATIC BILIARY SYSTEMK111627 · FGEIdev Technologies, Inc.510(k)Aug 21, 2012FDA decision date
SUPERA VERITAS Interwoven Self-Expanding Nitinol Stent Transhepatic Biliary System. Intended to be used for palliative treatment of biliary st…Z-1213-2012 · FGEIdev Technologies, Inc.RecallMar 15, 2012FDA classification date
SUPERA VERITAS INTERWOVEN SELF-EXPANDING NITINOL STENT TRANSHEPTIC BILIARY SYSTEMSK111766 · FGEIdev Technologies, Inc.510(k)Oct 19, 2011FDA decision date
SUPERA VERITAS INTERWOVEN SELF-EXPANDING NITINOL STENT TRANSHEPATIC BILIARY SYSTEMK093893 · FGEIdev Technologies, Inc.510(k)Oct 5, 2010FDA decision date
SUPERA INTERWOVEN SELF-EXPANDING BILIARY NITINOL STENT DELIVERY CATHETER, MODEL # S-04-040-120K071646 · FGEIdev Technologies, Inc.510(k)Jan 31, 2008FDA decision date
SURESAVE TM SELF-EXPANDABLE NITINOL STENT AND PRECISION TM DELIVERY CATHETER-SS06120060K060557 · FGEIdev Technologies, Inc.510(k)Aug 15, 2006FDA decision date
TEXAN LONGHORN FOREIGN BODY RETRIEVAL DEVICE, MODEL TX30120060K050926 · MMXIdev Technologies, Inc.510(k)May 9, 2005FDA decision date
AKONYA ELIMINATOR MECHANICAL THROMBECTOMY DEVICE, MODEL EL10060060K041374 · QEWIdev Technologies, Inc.510(k)Mar 2, 2005FDA decision date
TEXAN FOREIGN BODY RETRIEVAL DEVICE, MODEL TX30060050K033188 · MMXIdev Technologies, Inc.510(k)Nov 19, 2003FDA decision date
AKONYA ELIMINATOR MECHANICAL THROMBECTOMY DEVICE, MODEL EL 10060060K030504 · MCWIdev Technologies, Inc.510(k)Sep 16, 2003FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗